SCHEMBL3329308

SCHEMBL3329308

[CH2]N(Cc1ccccc1)C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.44
CTRB1 P17538 1/20 0.44
ALDH1A1 P00352 3/20 0.44
POLB P06746 1/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
ACHE P22303 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11378934 0.81 NPC1 (0.53) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL4018145 0.81 LMNA (0.56) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL2095210 0.79 NPC1 (0.67) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL27410434 0.79 NPC1 (0.50) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL6253791 0.78 NPC1 (0.50) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL28908035 0.78 NPC1 (0.50) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL6003103 0.76 NPC1 (0.57) NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL3665745 0.76 NPC1 (0.49) NPC1RAB9AKMT2AMEN1CA12
SCHEMBL15762363 0.76 LMNA (0.66) NPC1KMT2AMEN1LMNATSHR
SCHEMBL3328358 0.76 LMNA (0.51) NPC1RAB9AKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177519-B1 TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT NIPPON SODA CO (JP) 2015-05-27 EP disclosed
US-9029552-B2 Tetrazoyloxime derivative and plant disease control agent NIPPON SODA CO., LTD. (JP) 2015-05-12 US disclosed
US-20140005385-A1 TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2014-01-02 US disclosed
EP-2669282-A1 Tetrazoyloxime derivative and plant disease control agent NIPPON SODA CO., LTD. (JP) 2013-12-04 EP disclosed
US-20100137594-A1 TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT NIPPON SODA CO., LTD. (JP) 2010-06-03 US disclosed
EP-2177519-A1 TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT Nippon Soda Co., Ltd. (JP) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140005385-A1 TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT PAOX, BROX, TTI2 NPC1 3388/4885RAB9A 1891/4885KMT2A 720/4885
US-20100137594-A1 TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT PAOX, H1-10, HAX1 NPC1 2008/4885RAB9A 899/4885KMT2A 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.